DOCSLIB.ORG

Applications of Lasers in Medical Dermatology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Applications of Lasers in Medical Dermatology RPesidentediatric C doermatologyRneR Applications of Lasers in Medical Dermatology George Han, MD, PhD Lasers have become an important part of the Laser Treatment of Skin Diseases dermatologist’s arsenal for the treatment of skin Many common dermatoses seen in the dermatolo- diseases. As such, familiarity with the usage and gist’s office (eg, discoid lupus erythematosus [DLE], indications of this treatment modality has become morphea, alopecia) already have an established thera- important in the field of dermatology. In addition peutic ladder, with most patients responding to either to their numerous aesthetic indications, lasers first- or second-line therapies; however, a number of have proven to be efficacious in treating both pri- patients presentcopy with refractory disease that can be mary skin diseases and cutaneous malignancies. difficult to treat due to either treatment resistance or This article provides a review of the literature other contraindications to therapy. With the advent regarding laser treatment of selected skin con- and development of modern lasers, we are now able ditions to facilitate reasoned application of this to target many of these conditions and provide a via- therapeutic modality in dermatology. ble notsafe treatment option for these patients. Although Cutis. 2014;94:E20-E23. many physicians may be familiar with the use of the excimer laser in the treatment of psoriasis,1 a long- standing and well-accepted treatment modality for Dothis condition, many novel applications for different types of lasers have been developed. he use of lasers in dermatology has had a First, it is important to consider what a laser is able major impact on the treatment of many der- to accomplish to modulate the skin. With ablative Tmatologic conditions. In this column practi- lasers such as the CO2 laser, it is possible to destroy cal applications of lasers in medical dermatology superficial layers of the skin (ie, the epidermis). It will be discussed to give dermatology residents a would stand to reason that this approach would be broad overview of both establishedCUTIS indications and ideal for treating epidermal processes such as viral the reasoning behind the usage of lasers in treating warts; in fact, this modality has been used for this these skin conditions. The applications for lasers in indication for more than 3 decades, with the earliest aesthetic dermatology are numerous and are con- references coming from the podiatric and urologic stantly being refined and developed; they have been literature.2,3 Despite conflicting reports of the risk for discussed extensively in the literature. Given the human papillomavirus aerosolization and subsequent 4,5 vast variety of uses of lasers in dermatology today, a contamination of the treatment area, CO2 laser comprehensive review of this topic would likely span therapy has been advocated as a nonsurgical approach several volumes. This article will focus on recent to difficult-to-treat cases of viral warts. evidence regarding the use of lasers in medical On the other hand, the pulsed dye laser (PDL) can dermatology, specifically laser treatment of selected target blood vessels because the wavelength corre- common dermatoses and cutaneous malignancies. sponds to the absorption spectrum of hemoglobin and penetrates to the level of the dermis, while the pulse duration can be set to be shorter than the thermal From Albert Einstein College of Medicine/Montefiore relaxation time of a small cutaneous blood vessel.6 Medical Center, New York, New York. The author reports no conflict of interest. In clinical practice, the PDL has been used for the Correspondence: George Han, MD, PhD treatment of vascular lesions including hemangiomas, 7-9 ([email protected]). nevus flammeus, and other vascular proliferations. E20 CUTIS® WWW.CUTIS.COM Copyright Cutis 2014. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Resident Corner However, the PDL also can be used to target the ves- also the show effectiveness of both PDL and the CO2 sels in cutaneous inflammatory diseases that feature laser in treating lesions of cutaneous sarcoidosis, espe- vascular dilation and/or perivascular inflammation as cially lupus pernio.16-19 Of these 2 modalities, the use a prominent feature. of the CO2 laser for effective remodeling of lupus per- Discoid lupus erythematosus is a form of chronic nio may be more intuitive; however, it is still impor- cutaneous lupus erythematosus that may be difficult tant to note that the mechanism of action of several to treat, with recalcitrant lesions displaying contin- of these laser modalities is unclear with regard to the ued inflammation leading to chronic scarring and clinical benefit shown. Morphea and scleroderma also dyspigmentation. A small study (N12) presented have been treated with laser therapy. It is essential to the efficacy of the PDL in the treatment of DLE understand that in many cases, laser therapy may be lesions, suggesting that it has good efficacy in treat- targeted to treat the precise cutaneous manifestations ing recalcitrant lesions with significant reduction in of disease in each individual patient (eg, CO2 laser to the cutaneous lupus erythematosus disease area and treat disabling contractures and calcinosis cutis,20,21 severity index after 6 weeks of treatment and 6 weeks PDL to treat telangiectases related to morphea22). of follow-up (P.0001) with decreased erythema Again, the most critical consideration is that the and scaling.10 It is important to note, however, that treatment modality should align with the cutaneous scarring, dyspigmentation, and atrophy were not lesion being targeted. affected, which suggests that early intervention may A relatively recent development in the use of be optimal to prevent development of these sequelae. lasers has been LLLT, which refers to the use of lasers More interestingly, a more recent study expounded below levels where they would cause any thermal on this idea and attempted to examine pathophysio- effects, thereby limiting tissue damage. Although the logic mechanisms behind this observed improvement. technology has existed for decades, there has been a Evaluation of biopsy specimens before and after treat- recent flurry ofcopy reports extolling the many benefits ment and immunohistochemistry revealed that PDL of LLLT; however, the true physiologic effects of treatment of cutaneous DLE lesions led to a decrease LLLT have yet to be determined, with many studies in vascular endothelial proteins—intercellular trying to elucidate its numerous effects on various adhesion molecule 1 and vascular cell adhesion signalingnot pathways, cell proliferation, and cellular molecule 1—with a coincident reduction in the der- respiration.23-26 Upon reviewing the literature, the mal lymphocytic infiltrate in treated lesions.11 These list of cutaneous conditions that are being treated results offer a somewhat satisfying view on the cor- with LLLT is vast, spanning acne, vitiligo, wounds, relation between the theory and basic science of laserDo burns, psoriasis, and alopecia, among others.15 It is therapy and the subsequent clinical benefits afforded important to consider that the definition of LLLT by laser treatment. A case series provided further evi- in the literature is rather broad with a wide range of dence that PDL or intense pulsed light can ameliorate wavelengths, fluences, and power densities. As such, the cutaneous lesions of DLE in 16 patients in whom the specific laser settings and protocols may vary con- all other treatments had failed.12 siderably among different practitioners and therefore Several other inflammatory dermatoses can be the treatment results also may vary. Nevertheless, treated with PDL, though CUTISthe evidence for most of many studies have hinted at promising results in the these conditions is sporadic at best, consisting mostly use of LLLT in conditions that may have previously of case reports and a few case series. Granuloma faci- been extremely difficult to treat (eg, alopecia). Earlier ale is one such condition, with evidence of efficacy of trials had demonstrated a faster resolution time in the PDL dating back as far as 1999,13 though a more patients with alopecia areata when LLLT was added recent case series of 4 patients only showed response to a topical regimen27; however, the improvement in 2 patients.14 Because granuloma faciale features was modest and lesions tended to improve with or vasculitis as a prominent feature in its pathology, without LLLT. Perhaps more compelling is the use of targeting the blood vessels may be helpful, but it is LLLT in treating androgenetic alopecia, a condition important to remember that there is a complex inter- for which a satisfying facile treatment would truly play between multiple factors. For example, treat- carry great impact. Although physicians should be ment with typical fluences used in dermatology can cautious of studies regarding LLLT and hair regrowth be proinflammatory, leading to tissue damage, necro- that are conducted by groups who may stand to sis, and posttreatment erythema. However, low-level benefit from producing such a device, the results are laser therapy (LLLT) has been shown to downregulate nonetheless notable, if only for the relative paucity proinflammatory mediators.15 Additionally, the pres- of other therapeutic approaches toward this condi- ence of a large burden of inflammatory cells also may tion.28,29 A randomized, double-blind,
Load more

Recommended publications
  • July 2020 Goal the Goal of the Residency Program Is to Develop Future Leaders in Both Research and Clinical Medicine
    Residency Training Program July 2020 Goal The goal of the Residency Program is to develop future leaders in both research and clinical medicine. Flexibility within the program allows for the acquisition of fundamental working knowledge in all subspecialties of dermatology. All residents are taught a scholarly approach to patient care, aimed at integrating clinicopathologic observation with an understanding of the basic pathophysiologic processes of normal and abnormal skin. Penn’s Residency Program consists of conferences, seminars, clinical rotations, research, and an opportunity to participate in the teaching of medical students. An extensive introduction into the department and the William D. James, M.D. Director of Residency Program clinic/patient care service is given to first-year residents. A distinguished clinical faculty and research faculty, coupled with the clinical and laboratory facilities, provides residents with comprehensive training. An appreciation of and participation in the investigative process is an integral part of our residency. Graduates frequently earn clinical or basic science fellowship appointments at universities across the country. Examples of these include: pediatric dermatology, dermatopathology, dermatologic surgery, dermatoepidemiology, postdoctoral and Clinical Educator fellowships. Additional post graduate training has occurred at the NIH and CDC. Graduates of our program populate the faculty at Harvard, Penn, Johns Hopkins, MD Anderson, Dartmouth, Penn State, Washington University, and the Universities of Washington, Pittsburgh, Vermont, South Carolina, Massachusetts, Wisconsin, and the University of California San Francisco. Additionally, some enter private practice to become pillars of community medicine. Misha A. Rosenbach, M.D. Associate Director of Residency Program History The first medical school in America, founded in 1765, was named the College of Philadelphia.
    [Show full text]
  • Extrafacial Granuloma Faciale
    Journal of the American Osteopathic College of Dermatology Volume 11, Number 1 SPONSORS: ',/"!,0!4(/,/'9,!"/2!4/29s-%$)#)3 July 2008 34)%&%,,!"/2!4/2)%3s'!,$%2-! www.aocd.org Journal of the American Osteopathic College of Dermatology Journal of the American Osteopathic College of Dermatology 2007-2008 Officers President: Jay Gottlieb, DO President Elect: Donald Tillman, DO First Vice President: Marc Epstein, DO Second Vice President: Leslie Kramer, DO Third Vice President: Bradley Glick, DO Secretary-Treasurer: Jere Mammino, DO (2007-2010) Immediate Past President: Bill Way, DO Trustees: James Towry, DO (2006-2008) Mark Kuriata, DO (2007-2010) Karen Neubauer, DO (2006-2008) David Grice, DO (2007-2010) Sponsors: Global Pathology Laboratory Editors Stiefel Laboratories Jay S. Gottlieb, D.O., F.O.C.O.O. Medicis Stanley E. Skopit, D.O., F.A.O.C.D. James Q. Del Rosso, D.O., F.A.O.C.D. Galderma Editorial Review Board Ronald Miller, D.O. JAOCD Eugene Conte, D.O. Founding Sponsor Evangelos Poulos, M.D. Stephen Purcell, D.O. Darrel Rigel, M.D. !/#$s%)LLINOISs+IRKSVILLE -/ s&!8 Robert Schwarze, D.O. WWWAOCDORG Andrew Hanly, M.D. #/092)'(4!.$0%2-)33)/.WRITTENPERMISSIONMUSTBEOBTAINED Michael Scott, D.O. FROMTHE*OURNALOFTHE!MERICAN/STEOPATHIC#OLLEGEOF$ERMATOLOGY FORCOPYINGORREPRINTINGTEXTOFMORETHANHALFPAGE TABLESORlGURES Cindy Hoffman, D.O. 0ERMISSIONSARENORMALLYGRANTEDCONTINGENTUPONSIMILARPERMISSION Charles Hughes, D.O. FROMTHEAUTHORS INCLUSIONOFACKNOWLEDGEMENTOFTHEORIGINALSOURCE ANDAPAYMENTOFPERPAGE TABLEORlGUREOFREPRODUCEDMATERIAL Bill Way, D.O. 0ERMISSIONFEESAREWAIVEDFORAUTHORSWISHINGTOREPRODUCETHEIROWN Daniel Hurd, D.O. ARTICLES2EQUESTFORPERMISSIONSHOULDBEDIRECTEDTO*!/#$CO!/#$ 0/"OX+IRKSVILLE -/ Mark Lebwohl, M.D. #OPYRIGHTBYTHE*OURNALOFTHE!MERICAN/STEOPATHIC#OLLEGEOF Edward Yob, D.O. $ERMATOLOGY Jere Mammino, D.O. Printed by: Stoyles Graphics Services, Mason City, IA 50401 Schield M.
    [Show full text]
  • General Dermatology Practice Brochure
    Appointments Our Providers David A. Cowan, MD, FAAD We are currently accepting • Fellow, American Academy of Dermatology new patients. • Associate, American College of Call today to schedule your appointment Mohs Micrographic Surgery Monday - Friday, 8:00am to 4:30pm Rebecca G. Pomerantz, MD 1-877-661-3376 • Board Certified, American Academy of Cancellations & “No Show” Policy Dermatology If you are unable to keep your scheduled Lisa L. Ellis, MPAS, PA-C appointment, please call the office and we will • Member, American Academy of Physician be more than happy to reschedule for you. Assistants Failure to notify us at least 48 hours prior to your • Member, PA Society of Physician Assistants Medical and appointment may result in a cancellation fee. • Member, Society of Dermatology Physician Prescription Refills Assistants Surgical Refill requests are handled during normal office Sheri L. Rolewski, MSN, CRNP-BC hours when our staff has full access to medical • National Board Certification, Family Nurse Dermatology records. Refills cannot be called in on holidays, Practitioner Specialty weekends or more than twelve months after your • Member, Dermatology Nurse Association last exam. Please have your pharmacy contact our office directly. Test Results SMy Dermatology Appointment You will be notified when we receive your Date/Day _____________________________________ pathology or other test results, usually within two weeks from the date of your procedure. If you Time _________________________________________ do not hear from us within three
    [Show full text]
  • Dermatology at the Berkeley Outpatient Center
    Dermatology Berkeley Outpatient Center Overview Encompassing both medical and cosmetic dermatology, our experts at the Berkeley Outpatient Center offer a full range of diagnostic, treatment and surgical services for patients with cutaneous conditions. Surgical Dermatology • Fellowship-trained expertise in • Close coordination with Plastic Surgery Mohs micrographic surgery for at the Berkeley Outpatient Center, treatment of skin cancers including allowing for streamlined treatment for basal cell carcinomas and squamous related procedures in one location cell carcinomas, as well as treatment of • Outpatient surgery for removal of melanoma in situ with MART-1 staining benign skin growths and skin cancers Medical Dermatology - Conditions Treated/Services Offered • Acne, rosacea and related conditions • Mole/Atypical nevus/Melanoma • Sun-damaged skin surveillance • Aesthetic/Cosmetic dermatology • Non-melanoma skin cancers • Eczema and atopic dermatitis • Pigmentation disorders • HIV/AIDS-related skin conditions • Psoriasis • Lumps under the skin • Rashes • Infections of the skin (bacterial, viral, • Skin checks for patients with fungal and other) concerning lesions • Melanoma • Warts When to see a Dermatologist For more information, please call Dermatology Services at (510) 985-5200. Dermatology Services Providing integrated care in the community. Our Dermatology Team Erin Amerson, MD Drew Saylor, MD, MPH UCSF Health UCSF Health Dermatologist Dermatologic surgeon To learn more about our doctors, visit ucsfhealth.org/find_a_doctor. Office location: Berkeley Outpatient Center 3100 San Pablo Avenue Berkeley, CA 94702 (510) 985-5200 To learn more about our Berkeley Outpatient Center, Adeline St visit johnmuirhealth.com/ September 2020 berkeleyopc..
    [Show full text]
  • Urticaria from Wikipedia, the Free Encyclopedia Jump To: Navigation, Search "Hives" Redirects Here
    Urticaria From Wikipedia, the free encyclopedia Jump to: navigation, search "Hives" redirects here. For other uses, see Hive. Urticaria Classification and external resourcesICD-10L50.ICD- 9708DiseasesDB13606MedlinePlus000845eMedicineemerg/628 MeSHD014581Urtic aria (or hives) is a skin condition, commonly caused by an allergic reaction, that is characterized by raised red skin wheals (welts). It is also known as nettle rash or uredo. Wheals from urticaria can appear anywhere on the body, including the face, lips, tongue, throat, and ears. The wheals may vary in size from about 5 mm (0.2 inches) in diameter to the size of a dinner plate; they typically itch severely, sting, or burn, and often have a pale border. Urticaria is generally caused by direct contact with an allergenic substance, or an immune response to food or some other allergen, but can also appear for other reasons, notably emotional stress. The rash can be triggered by quite innocent events, such as mere rubbing or exposure to cold. Contents [hide] * 1 Pathophysiology * 2 Differential diagnosis * 3 Types * 4 Related conditions * 5 Treatment and management o 5.1 Histamine antagonists o 5.2 Other o 5.3 Dietary * 6 See also * 7 References * 8 External links [edit] Pathophysiology Allergic urticaria on the shin induced by an antibiotic The skin lesions of urticarial disease are caused by an inflammatory reaction in the skin, causing leakage of capillaries in the dermis, and resulting in an edema which persists until the interstitial fluid is absorbed into the surrounding cells. Urticarial disease is thought to be caused by the release of histamine and other mediators of inflammation (cytokines) from cells in the skin.
    [Show full text]
  • Dermatology Patch Allergy Testing Post Service - Information Request Form
    Dermatology Patch Allergy Testing Post Service - Information Request Form Blue Cross NC will review associated claim(s) for services rendered on the patient listed below. In order to determine benefits are available for the reported condition, please answer the questions below. If you would prefer to send medical records, relating to the condition for the dates listed you may do so. In this case, all answers must be supported by documentation in the patient's medical record. Please submit the completed form to Blue Cross NC per the Medical Record Submission instructions found on the bcbsnc.com provider site (https://www.bcbsnc.com/assets/providers/public/pdfs/submissions/how_to_submit_provider_initiated_medical_records.pdf) or if requested by Blue Cross NC via a bar-coded coversheet, please fax the form/medical records to the number noted on the bar-coded cover sheet within 7-10 days to facilitate the claim payment. This form must be filled out by the patient's physician or their designee which may be any of the following: Physician Assistant (PA), Nurse Practitioner (NP), Registered Nurse (RN), or Licensed Practical Nurse (LPN). Note: Credentials must be provided with signature or the form will be returned. PROVIDER INFORMATION Requesting Provider Information Place of Service Provider Name Facility Name Provider ID Facility ID PATIENT INFORMATION Patient Name:_____________________________ Patient DOB :_____________ Patient Account Number______________ Patient ID:______________ CLAIM INFORMATION Date(s) of Service_____________ CPT_________ Diagnosis_______ Dermatology Patch Allergy Testing - Information Request Form Page 1 of 3 CLINICAL INFORMATION Did the patient have direct skin testing (for immediate hypersensitivity) by: Percutaneous or epicutaneous (scratch, prick, or puncture)? ________________ Intradermal testing? ___________________________________ Inhalant allergy evaluation? _________________ Did the patient have patch (application) testing (most commonly used: T.R.U.E.
    [Show full text]
  • Fundamentals of Dermatology Describing Rashes and Lesions
    Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous,
    [Show full text]
  • Dermatopathology
    Dermatopathology Clay Cockerell • Martin C. Mihm Jr. • Brian J. Hall Cary Chisholm • Chad Jessup • Margaret Merola With contributions from: Jerad M. Gardner • Talley Whang Dermatopathology Clinicopathological Correlations Clay Cockerell Cary Chisholm Department of Dermatology Department of Pathology and Dermatopathology University of Texas Southwestern Medical Center Central Texas Pathology Laboratory Dallas , TX Waco , TX USA USA Martin C. Mihm Jr. Chad Jessup Department of Dermatology Department of Dermatology Brigham and Women’s Hospital Tufts Medical Center Boston , MA Boston , MA USA USA Brian J. Hall Margaret Merola Department of Dermatology Department of Pathology University of Texas Southwestern Medical Center Brigham and Women’s Hospital Dallas , TX Boston , MA USA USA With contributions from: Jerad M. Gardner Talley Whang Department of Pathology and Dermatology Harvard Vanguard Medical Associates University of Arkansas for Medical Sciences Boston, MA Little Rock, AR USA USA ISBN 978-1-4471-5447-1 ISBN 978-1-4471-5448-8 (eBook) DOI 10.1007/978-1-4471-5448-8 Springer London Heidelberg New York Dordrecht Library of Congress Control Number: 2013956345 © Springer-Verlag London 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work.
    [Show full text]
  • Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction
    HOW I DO IT/BACK TO BASICS This new feature will emphasize innovative and better ways to perform dermatologic surgery procedures. This ar- ticle should be based on some evidence-based literature, but may describe the author’s experience with a particular procedure without being a typical clinical research article. The Editor will consider ideas for topics. Any author who is considering writing an article should submit the title to Ronald L. Moy, MD, Editor-in-Chief, 100 UCLA Medical Plaza, Suite 590, Los Angeles, CA 90024. Concepts of Sliding and Lifting Tissue Movement in Flap Reconstruction Timothy M. Johnson, MD,*†‡ Neil Swanson, MD,§ and Shan R. Baker, MD† Departments of *Dermatology, †Otorhinolaryngology, and ‡Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, and §Department of Dermatology and Otolaryngology, Oregon Health Sciences, Portland Oregon background. The optimal design of a skin flap requires an the answer to three predictable events that result from tissue understanding of the concepts of tissue movement. transfer: Where is the tension? Where are the final incision objective. The purpose of this manuscript was to demon- lines? Where is the redundant tissue? strate concepts of sliding and lifting tissue movement for flap conclusion. A mental exercise assessing all available recon- reconstruction. struction options should be performed for each individual pa- methods. Six similar defects located in the forehead–temple– tient and defect. Both patient and defect considerations need to eyebrow region were repaired using a different skin flap. be assessed. A thorough understanding of both anatomy and tis- results. The specific flap design for a given defect is based on sue movement is necessary for optimal skin flap reconstruction.
    [Show full text]
  • CO2 - CO2 Laser Physics 111B: Advanced Experimentation Laboratory University of California, Berkeley
    CO2 - CO2 Laser Physics 111B: Advanced Experimentation Laboratory University of California, Berkeley Contents 1 CO2 Laser Description (CO2)1 2 The CO2 Laser Experiment Photos2 3 Before the 1st Day of Lab3 4 Objectives 4 5 Introduction 4 5.1 Safety Measures............................................ 4 6 Equipment 5 7 Standard Operating Procedure (SOP) for the CO2 Laser6 7.1 Alignment Procedure......................................... 6 7.2 Pumping-Out and Filling the Laser Tube ............................. 7 7.3 Power-On and -Off, and Maximizing Laser Power......................... 9 8 Experiments 11 8.1 Current-voltage Curve and Gas Pressure.............................. 11 8.2 Power Threshold ........................................... 11 8.3 Output Power Stability ....................................... 11 8.4 Laser Spectrum............................................ 12 8.4.1 Beam-Finding......................................... 12 8.4.2 The Spectrum Analyzer (Spectrometer).......................... 12 9 Apparatus Layout 15 10 References 16 1 CO2 Laser Description (CO2) 1. Note that there is NO eating or drinking in the 111-Lab anywhere, except in rooms 282 & 286 LeConte on the bench with the BLUE stripe around it. Thank you { the Staff. The carbon dioxide laser was the first high-powered infrared laser developed. The one in our laboratory is a new version that everything about it is something you can see, touch and adjust { from filling the tube with gas, aligning the optical elements to measuring the output power and wavelengths. Its output can exceed 10 watts of monochromatic radiation, enough to burn you in a fraction of a second. So be careful with what you vary. In this experiment, you will learn about molecular structure, light and optics, and gas discharges. You will develop skills in adjusting sensitive optical equipment.
    [Show full text]
  • Basal Cell Carcinoma Associated with Non-Neoplastic Cutaneous Conditions: a Comprehensive Review
    Volume 27 Number 2| February 2021 Dermatology Online Journal || Review 27(2):1 Basal cell carcinoma associated with non-neoplastic cutaneous conditions: a comprehensive review Philip R Cohen MD1,2 Affiliations: 1San Diego Family Dermatology, National City, California, USA, 2Touro University California College of Osteopathic Medicine, Vallejo, California, USA Corresponding Author: Philip R Cohen, 10991 Twinleaf Court, San Diego, CA 92131-3643, Email: [email protected] pathogenesis of BCC is associated with the Abstract hedgehog signaling pathway and mutations in the Basal cell carcinoma (BCC) can be a component of a patched homologue 1 (PCTH-1) transmembrane collision tumor in which the skin cancer is present at tumor-suppressing protein [2-4]. Several potential the same cutaneous site as either a benign tumor or risk factors influence the development of BCC a malignant neoplasm. However, BCC can also concurrently occur at the same skin location as a non- including exposure to ultraviolet radiation, genetic neoplastic cutaneous condition. These include predisposition, genodermatoses, immunosuppression, autoimmune diseases (vitiligo), cutaneous disorders and trauma [5]. (Darier disease), dermal conditions (granuloma Basal cell carcinoma usually presents as an isolated faciale), dermal depositions (amyloid, calcinosis cutis, cutaneous focal mucinosis, osteoma cutis, and tumor on sun-exposed skin [6-9]. However, they can tattoo), dermatitis, miscellaneous conditions occur as collision tumors—referred to as BCC- (rhinophyma, sarcoidal reaction, and varicose veins), associated multiple skin neoplasms at one site scars, surgical sites, systemic diseases (sarcoidosis), (MUSK IN A NEST)—in which either a benign and/or systemic infections (leischmaniasis, leprosy and malignant neoplasm is associated with the BCC at lupus vulgaris), and ulcers.
    [Show full text]
  • Treatment Or Removal of Benign Skin Lesions
    Treatment or Removal of Benign Skin Lesions Date of Origin: 10/26/2016 Last Review Date: 03/24/2021 Effective Date: 04/01/2021 Dates Reviewed: 10/2016, 10/2017, 10/2018, 04/2019, 10/2019, 01/2020, 03/2020, 03/2021 Developed By: Medical Necessity Criteria Committee I. Description Individuals may acquire a multitude of benign skin lesions over the course of a lifetime. Most benign skin lesions are diagnosed on the basis of clinical appearance and history. If the diagnosis of a lesion is uncertain, or if a lesion has exhibited unexpected changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated to confirm the diagnosis. The treatment of benign skin lesions consists of destruction or removal by any of a wide variety of techniques. The removal of a skin lesion can range from a simple biopsy, scraping or shaving of the lesion, to a radical excision that may heal on its own, be closed with sutures (stitches) or require reconstructive techniques involving skin grafts or flaps. Laser, cautery or liquid nitrogen may also be used to remove benign skin lesions. When it is uncertain as to whether or not a lesion is cancerous, excision and laboratory (microscopic) examination is usually necessary. II. Criteria: CWQI HCS-0184A Note: **If request is for treatment or removal of warts, medical necessity review is not required** A. Moda Health will cover the treatment and removal of 1 or more of the following benign skin lesions: a. Treatment or removal of actinic keratosis (pre-malignant skin lesions due to sun exposure) is considered medically necessary with 1 or more of the following procedures: i.
    [Show full text]